
Updates from #ASCO23: ER+/HER- Localized Breast CA & the NATALEE Trial
Two Onc Docs
00:00
Exploring Current Standard of Care and Interim Analysis of NATALEE Trial in Breast Cancer Treatment
Exploring the use of adjuvant CDK46 inhibitor with endocrine therapy, insights from the Monarch and NATALEE trials, and expanding patient inclusion criteria to improve care standards.
Transcript
Play full episode